HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
cordialin
RN given refers to compound with unknown MF
Networked:
3
relevant articles (
0
outcomes,
1
trials/studies)
Bio-Agent Context: Research Results
Amino Acids, Peptides, and Proteins: 1
Proteins: 484843
Intercellular Signaling Peptides and Proteins: 29768
cordialin: 3
Peptides: 82426
Intercellular Signaling Peptides and Proteins: 29768
cordialin: 3
Biological Factors: 2472
Intercellular Signaling Peptides and Proteins: 29768
cordialin: 3
Related Diseases
1.
Ischemia
08/01/1990 - "
Based on experimental studies the possibility of cordialin use in acute ischemia is being substantiated.
"
07/01/1991 - "
The results received may be a theoretical basis for cordialin utilization in therapy of myocardial diseases, associated with hypoxia and ischemia.
"
03/01/1992 - "
Cordialin correction of the biologic energy of cardiomyocytes in hypoxia and ischemia prevents the accumulation of lipid drops in the cells of the peri-infarction zone, which reflects the high intensity of the processes of fatty acids beta-oxidation.
"
2.
Myocardial Infarction
08/01/1990 - "
Cordialin use in early stages of myocardial infarction is suggested.
"
07/01/1991 - "
Cordialin utilization may be recommended for the treatment of acute myocardial infarction and for prolongation of time-period for thrombolytic therapy, treatment of IMD, angina and other pathological states, in which oxygen transport disturbance to myocardium cells occurs.
"
3.
Hypoxia (Hypoxemia)
07/01/1991 - "
The results received may be a theoretical basis for cordialin utilization in therapy of myocardial diseases, associated with hypoxia and ischemia.
"
07/01/1991 - "
Cordialin, the agent extracted from the heart, is known to inhibit hyperoxidation of succinic acid, increasing NADH oxidation speed in suspension of cardiomyocytes in hypoxia.
"
03/01/1992 - "
Cordialin correction of the biologic energy of cardiomyocytes in hypoxia and ischemia prevents the accumulation of lipid drops in the cells of the peri-infarction zone, which reflects the high intensity of the processes of fatty acids beta-oxidation.
"
4.
Cardiomyopathies (Cardiomyopathy)
07/01/1991 - "
The results received may be a theoretical basis for cordialin utilization in therapy of myocardial diseases, associated with hypoxia and ischemia.
"
5.
Infarction (Infarctions)
03/01/1992 - "
Cordialin correction of the biologic energy of cardiomyocytes in hypoxia and ischemia prevents the accumulation of lipid drops in the cells of the peri-infarction zone, which reflects the high intensity of the processes of fatty acids beta-oxidation.
"
Related Drugs and Biologics
1.
Succinic Acid (Succinate)
2.
Suspensions
3.
Oxygen (Dioxygen)
4.
NAD (NADH)
5.
Lipids
6.
Fatty Acids (Saturated Fatty Acids)
Related Therapies and Procedures
1.
Thrombolytic Therapy
2.
Therapeutics